September 2019 – September 2020
In September 2019, NSLHD launched its inaugural five year Research Strategy 2019-2024 after six months of consultation across the district. The implementation of the initiatives within the Strategy is overseen by the NSLHD Research Advisory Committee, a group that meets bi-monthly and is chaired by the Chief Executive, Deborah Willcox.
Our ethics and governance team reviewed 147 ethics applications, and 185 governance applications over the last twelve months.
Prof Jim Elliott, Prof JimMiddleton, Prof Ashley Craig and NEURA colleagues received $2.5 million via the Spinal Cord Injury Research Grants scheme for their project RESTORE: Immersive Virtual Reality Treatment for Restoring Touch Perception in People with Discomplete Paraplegia (2020-2025) .
Ms Sally McCowatt, Manager of the NSLHD Oncology and Radiation Oncology Clinical Trials Unit, accepting the prestigious award on behalf of the unit
In 2019, NSLHD’s oncology trials unit won the NSW Premier’s Awards for Outstanding Cancer Research, in the category of Outstanding Cancer Clinical Trials Unit. The unit demonstrated a strategic approach to trial selection that led to over 60 per cent of trials recruiting to target.
Made with FlippingBook - professional solution for displaying marketing and sales documents online